Brief: Hansoh Pharmaceutical Says NMPA Accepts Biologics License Application Of HS-20093
02/09/2026 09:31
BRIEF-Hansoh Pharmaceutical Says NMPA Accepts Biologics License Application Of HS-20093 Sept 2 (Reuters) - Hansoh Pharmaceutical 3692.HK:
NMPA ACCEPTS BIOLOGICS LICENSE APPLICATION OF HS-20093 FOR SMALL CELL LUNG CANCER
Further company coverage: 3692.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion